
|Videos|March 17, 2021
Refining Combination Strategies in Metastatic RCC
Author(s)Toni K. Choueiri, MD, Robert J. Motzer, MD
Drs Toni Choueiri and Robert J. Motzer reflect on recent data supporting the use of TKI/I-O combination regimens for frontline treatment of metastatic renal cell carcinoma.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Camizestrant for ESR1-Mutated HR+/HER2– Advanced Breast Cancer
2
Novel Agent Earns FDA Breakthrough Therapy Designation for HPV+ Oropharyngeal Cancer
3
Debating Camizestrant, ctDNA Monitoring, and SERENA-6 in HR+ Breast Cancer
4
Saturated Fat Intake Linked to Greater Mortality in Nonmetastatic Prostate Cancer
5


























































